Milestones in the pathogenesis and management of primary liver cancer
Journal
Journal of Hepatology
Journal Volume
72
Journal Issue
2
Pages
209-214
Date Issued
2020
Author(s)
SDGs
Other Subjects
protein tyrosine kinase inhibitor; antineoplastic antimetabolite; protein kinase inhibitor; advanced cancer; bile duct carcinoma; cancer combination chemotherapy; cancer epidemiology; cancer immunotherapy; cancer surgery; cancer therapy; clinical assessment; Editorial; hepatography; human; liver carcinogenesis; liver cell carcinoma; liver transplantation; medical history; nonhuman; priority journal; radiation response; systemic therapy; adjuvant chemoradiotherapy; bile duct cancer; bile duct carcinoma; chemoembolization; immunotherapy; liver cell carcinoma; liver tumor; pathology; procedures; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemoradiotherapy, Adjuvant; Cholangiocarcinoma; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Liver Neoplasms; Protein Kinase Inhibitors
Publisher
Elsevier B.V.
Type
editorial